NCT05116891 2023-07-03A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid TumorsCantargia ABPhase 1/2 Completed40 enrolled
NCT04165031 2021-11-24A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C MutationEli Lilly and CompanyPhase 1/2 Terminated5 enrolled 9 charts
NCT00003103 2013-07-03Chemotherapy in Treating Patients With Solid TumorsMemorial Sloan Kettering Cancer CenterPhase 1/2 Completed57 enrolled